Arkolith/Insider Trading/GERN/Form 4

Eid Joseph

EVP, R&D; Chief Medical OfficeGERON CORP (GERN) · full profile →Form 4 · filed Feb 19, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 17, 2026Grant(A)2.2M—$02.2M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780247-26-000001) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML